JP2010518386A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010518386A5 JP2010518386A5 JP2009548631A JP2009548631A JP2010518386A5 JP 2010518386 A5 JP2010518386 A5 JP 2010518386A5 JP 2009548631 A JP2009548631 A JP 2009548631A JP 2009548631 A JP2009548631 A JP 2009548631A JP 2010518386 A5 JP2010518386 A5 JP 2010518386A5
- Authority
- JP
- Japan
- Prior art keywords
- hemoglobin
- level
- sample
- free
- pregnant female
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010044495 Fetal Hemoglobin Proteins 0.000 claims 17
- 241000124008 Mammalia Species 0.000 claims 13
- 201000011461 pre-eclampsia Diseases 0.000 claims 12
- 239000000523 sample Substances 0.000 claims 12
- 238000000034 method Methods 0.000 claims 11
- 239000012472 biological sample Substances 0.000 claims 10
- 108010054147 Hemoglobins Proteins 0.000 claims 9
- 102000001554 Hemoglobins Human genes 0.000 claims 9
- 239000012634 fragment Substances 0.000 claims 5
- 239000011230 binding agent Substances 0.000 claims 3
- 208000002296 eclampsia Diseases 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 210000002700 urine Anatomy 0.000 claims 3
- 102000007513 Hemoglobin A Human genes 0.000 claims 2
- 108010085682 Hemoglobin A Proteins 0.000 claims 2
- 238000003149 assay kit Methods 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 230000001605 fetal effect Effects 0.000 claims 2
- 150000003278 haem Chemical class 0.000 claims 2
- 230000002163 immunogen Effects 0.000 claims 2
- 210000005059 placental tissue Anatomy 0.000 claims 2
- 230000036470 plasma concentration Effects 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 238000004393 prognosis Methods 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 102000009027 Albumins Human genes 0.000 claims 1
- 108010088751 Albumins Proteins 0.000 claims 1
- 102000003966 Alpha-1-microglobulin Human genes 0.000 claims 1
- 101800001761 Alpha-1-microglobulin Proteins 0.000 claims 1
- 102000008857 Ferritin Human genes 0.000 claims 1
- 108050000784 Ferritin Proteins 0.000 claims 1
- 238000008416 Ferritin Methods 0.000 claims 1
- 102000016761 Haem oxygenases Human genes 0.000 claims 1
- 108050006318 Haem oxygenases Proteins 0.000 claims 1
- 108091005886 Hemoglobin subunit gamma Proteins 0.000 claims 1
- 102100038617 Hemoglobin subunit gamma-2 Human genes 0.000 claims 1
- 102000013271 Hemopexin Human genes 0.000 claims 1
- 108010026027 Hemopexin Proteins 0.000 claims 1
- 102000008133 Iron-Binding Proteins Human genes 0.000 claims 1
- 108010035210 Iron-Binding Proteins Proteins 0.000 claims 1
- 102000004338 Transferrin Human genes 0.000 claims 1
- 108090000901 Transferrin Proteins 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000006731 degradation reaction Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 210000003754 fetus Anatomy 0.000 claims 1
- 210000000265 leukocyte Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000012581 transferrin Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0700339-5 | 2007-02-12 | ||
| SE0700339 | 2007-02-12 | ||
| PCT/EP2008/001051 WO2008098734A1 (en) | 2007-02-12 | 2008-02-12 | Diagnosis and treatment of preeclampsia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013150603A Division JP5792772B2 (ja) | 2007-02-12 | 2013-07-19 | 子癇前症の診断及び治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010518386A JP2010518386A (ja) | 2010-05-27 |
| JP2010518386A5 true JP2010518386A5 (enExample) | 2011-03-31 |
| JP5604111B2 JP5604111B2 (ja) | 2014-10-08 |
Family
ID=39295873
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009548631A Expired - Fee Related JP5604111B2 (ja) | 2007-02-12 | 2008-02-12 | 子癇前症の診断及び治療 |
| JP2013150603A Expired - Fee Related JP5792772B2 (ja) | 2007-02-12 | 2013-07-19 | 子癇前症の診断及び治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013150603A Expired - Fee Related JP5792772B2 (ja) | 2007-02-12 | 2013-07-19 | 子癇前症の診断及び治療 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US8568999B2 (enExample) |
| EP (3) | EP2613150A1 (enExample) |
| JP (2) | JP5604111B2 (enExample) |
| KR (2) | KR101608501B1 (enExample) |
| AU (1) | AU2008214837B2 (enExample) |
| BR (1) | BRPI0808340A2 (enExample) |
| CA (1) | CA2674204C (enExample) |
| DK (2) | DK2111555T3 (enExample) |
| EA (2) | EA022609B1 (enExample) |
| ES (2) | ES2599003T3 (enExample) |
| HR (2) | HRP20130809T1 (enExample) |
| HU (1) | HUE031613T2 (enExample) |
| MX (2) | MX2009008408A (enExample) |
| NZ (1) | NZ578077A (enExample) |
| PL (2) | PL2614832T3 (enExample) |
| PT (2) | PT2614832T (enExample) |
| WO (1) | WO2008098734A1 (enExample) |
| ZA (1) | ZA200905101B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101608501B1 (ko) * | 2007-02-12 | 2016-04-04 | 에이원엠 파마 에이비 | 자간전증의 진단 및 치료 |
| ES2614490T3 (es) * | 2008-07-18 | 2017-05-31 | A1M Pharma Ab | Uso médico de la alfa 1-microglobulina antioxidante y eliminadora de radicales |
| WO2011095981A1 (en) * | 2010-02-03 | 2011-08-11 | St. John's Research Institute | An in-vitro method for characterizing hemoglobin variant |
| NZ602733A (en) | 2010-03-24 | 2014-03-28 | Preelumina Diagnostics Ab | Hbf and a1m as early stage markers for preeclampsia |
| JP5914326B2 (ja) * | 2010-03-31 | 2016-05-11 | 積水メディカル株式会社 | イムノクロマトグラフィーを利用した測定方法、イムノクロマトグラフィー用テストストリップ及びイムノクロマトグラフィー用測定試薬キット |
| WO2013053359A1 (en) | 2011-10-14 | 2013-04-18 | Aarhus Universitet | Diagnostic and prognostic use of prombp-complexes |
| JP2015533790A (ja) * | 2012-09-05 | 2015-11-26 | エー１エム ファーマ エービーＡ１Ｍ Ｐｈａｒｍａ ＡＢ | ミトコンドリア関連疾患の治療に使用するためのα−１−ミクログロブリン |
| US10928402B2 (en) | 2012-12-28 | 2021-02-23 | Nx Prenatal Inc. | Treatment of spontaneous preterm birth |
| US20140186332A1 (en) * | 2012-12-28 | 2014-07-03 | NX Pharmagen | Biomarkers of preterm birth |
| AU2016232309A1 (en) | 2015-03-16 | 2017-09-28 | A1M Pharma AB. | Biomarkers for preeclampsia |
| KR101732933B1 (ko) | 2015-07-29 | 2017-05-08 | 영남대학교 산학협력단 | 신생아의 성장 또는 심혈관계 질환 예후 진단 방법 |
| CN109072479A (zh) | 2015-12-04 | 2018-12-21 | Nx产前公司 | 使用循环微粒对自发性早产风险进行分层 |
| US12253490B2 (en) | 2018-03-19 | 2025-03-18 | Regeneron Pharmaceuticals, Inc. | Microchip capillary electrophoresis assays and reagents |
| US12259355B2 (en) | 2018-03-19 | 2025-03-25 | Regeneron Pharmaceuticals, Inc. | Microchip capillary electrophoresis assays and reagents |
| HUE065344T2 (hu) * | 2018-03-19 | 2024-05-28 | Regeneron Pharma | Mikrochip kapilláris elektroforézis assay-k és reagensek |
| US11418353B2 (en) * | 2019-08-26 | 2022-08-16 | Micron Technology, Inc. | Security descriptor generation |
| CN111626280B (zh) * | 2020-04-13 | 2021-09-07 | 北京邮电大学 | 一种无定位点答题卡识别方法和装置 |
| WO2024053586A1 (ja) * | 2022-09-05 | 2024-03-14 | 栄研化学株式会社 | 遊離ヘモグロビン測定試薬、遊離ヘモグロビン測定方法および抗ヘモグロビン抗体 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1337778A1 (ru) | 1984-06-25 | 1987-09-15 | Новосибирский государственный медицинский институт | Способ диагностики т жести позднего токсикоза беременных |
| US5079171A (en) | 1988-09-15 | 1992-01-07 | Adeza Biomedical Corporation | Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin |
| US5238819A (en) | 1988-12-14 | 1993-08-24 | The Regents Of The University Of California | Diagnostic assay for the detection of preeclampsia |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5108898A (en) | 1989-01-18 | 1992-04-28 | Peters John H | Use of fibronectin having a variable included type III repeat sequence as a marker for toxemia in pregnancy |
| US5612034A (en) * | 1990-10-03 | 1997-03-18 | Redcell, Inc. | Super-globuling for in vivo extended lifetimes |
| US5166133A (en) | 1991-04-17 | 1992-11-24 | Cetus Corporation | Method for inhibing adhesion of white blood cells to endothelial cells |
| US6103691A (en) | 1994-03-23 | 2000-08-15 | Tschesche; Harald | Utilisation of angiogenin and/or α1 -microglobulin and/or complement factor D in order to inhibit the secretion of proteins |
| US5849474A (en) * | 1995-12-06 | 1998-12-15 | Olson; Camilla M. | Diagnosis of preeclampsia in mammals |
| US5910482A (en) * | 1996-03-19 | 1999-06-08 | Board Of Regents, The University Of Texas System | Treatment or prevention of preeclampsia, eclampsia with calcitonin gene related peptide, CGRP analog, progestational agent, nitric oxide source, and cyclooxygenase inhibitor |
| US6169816B1 (en) * | 1997-05-14 | 2001-01-02 | Applied Imaging, Inc. | Identification of objects of interest using multiple illumination schemes and finding overlap of features in corresponding multiple images |
| JP2001348342A (ja) | 2001-04-12 | 2001-12-18 | Nippon Zoki Pharmaceut Co Ltd | 免疫調整・抗炎症剤 |
| JP3806694B2 (ja) | 2001-05-04 | 2006-08-09 | バイオサイト インコーポレイテッド | 急性冠状動脈症候群の診断マーカーおよびその使用方法 |
| EP1423706B1 (en) | 2001-09-04 | 2007-04-18 | IQ Corporation B.V. | Determination and quantification of red blood cell populations in samples |
| WO2003083479A1 (en) * | 2002-03-29 | 2003-10-09 | Matsushita Electric Industrial Co., Ltd. | Blood processing method, blood processing device, method of measuring hemoglobins and device for measuring hemoglobins |
| DE10237423A1 (de) | 2002-08-16 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen |
| JP5624256B2 (ja) * | 2003-06-20 | 2014-11-12 | ラプター・ファーマシューティカル・インコーポレイテッド | 脳および他の組織への治療化合物の送達 |
| AR045074A1 (es) | 2003-07-23 | 2005-10-12 | Applied Research Systems | Uso de cd164 soluble en desordenes inflamatorios y autoinmunes |
| BRPI0416906A (pt) * | 2003-11-26 | 2007-01-16 | Sanofi Aventis Deutschland | proteinúria tubular como um indicador para risco cardiovascular elevado |
| WO2005093413A2 (en) | 2004-03-22 | 2005-10-06 | Yale University | Diagnosis and treatment of preeclampsia |
| US20070292421A1 (en) * | 2005-07-28 | 2007-12-20 | Feinberg Bruce B | Method for treating preeclampsia |
| GB0600916D0 (en) | 2006-01-17 | 2006-02-22 | Perkinelmer Instr Las Inc | detecting and predicting pre-eclampsia |
| WO2007082757A2 (en) | 2006-01-18 | 2007-07-26 | Wick, Immunologische Diagnostik U. Beratung Kg | Test systems for the analysis of polypeptides and cells adhering to silicones |
| KR101608501B1 (ko) | 2007-02-12 | 2016-04-04 | 에이원엠 파마 에이비 | 자간전증의 진단 및 치료 |
| WO2009108073A1 (en) | 2008-02-28 | 2009-09-03 | Auckland Uniservices Limited | Biomarkers for prediction of preeclampsia and/or cardiovascular disease |
| ES2614490T3 (es) | 2008-07-18 | 2017-05-31 | A1M Pharma Ab | Uso médico de la alfa 1-microglobulina antioxidante y eliminadora de radicales |
| NZ602733A (en) | 2010-03-24 | 2014-03-28 | Preelumina Diagnostics Ab | Hbf and a1m as early stage markers for preeclampsia |
-
2008
- 2008-02-12 KR KR1020147017284A patent/KR101608501B1/ko not_active Expired - Fee Related
- 2008-02-12 US US12/526,941 patent/US8568999B2/en not_active Expired - Fee Related
- 2008-02-12 PT PT131602757T patent/PT2614832T/pt unknown
- 2008-02-12 EP EP13160278.1A patent/EP2613150A1/en not_active Withdrawn
- 2008-02-12 EP EP08707674.1A patent/EP2111555B1/en not_active Not-in-force
- 2008-02-12 WO PCT/EP2008/001051 patent/WO2008098734A1/en not_active Ceased
- 2008-02-12 EP EP13160275.7A patent/EP2614832B1/en not_active Not-in-force
- 2008-02-12 DK DK08707674.1T patent/DK2111555T3/da active
- 2008-02-12 AU AU2008214837A patent/AU2008214837B2/en not_active Ceased
- 2008-02-12 BR BRPI0808340A patent/BRPI0808340A2/pt not_active Application Discontinuation
- 2008-02-12 PL PL13160275T patent/PL2614832T3/pl unknown
- 2008-02-12 HR HRP20130809AT patent/HRP20130809T1/hr unknown
- 2008-02-12 JP JP2009548631A patent/JP5604111B2/ja not_active Expired - Fee Related
- 2008-02-12 HU HUE13160275A patent/HUE031613T2/en unknown
- 2008-02-12 PL PL08707674T patent/PL2111555T3/pl unknown
- 2008-02-12 KR KR1020097019056A patent/KR101454013B1/ko not_active Expired - Fee Related
- 2008-02-12 CA CA2674204A patent/CA2674204C/en not_active Expired - Fee Related
- 2008-02-12 DK DK13160275.7T patent/DK2614832T3/da active
- 2008-02-12 ES ES13160275.7T patent/ES2599003T3/es active Active
- 2008-02-12 EA EA200970758A patent/EA022609B1/ru not_active IP Right Cessation
- 2008-02-12 MX MX2009008408A patent/MX2009008408A/es active IP Right Grant
- 2008-02-12 EA EA201500335A patent/EA031877B1/ru not_active IP Right Cessation
- 2008-02-12 ES ES08707674T patent/ES2426069T3/es active Active
- 2008-02-12 MX MX2013001577A patent/MX347788B/es unknown
- 2008-02-12 NZ NZ578077A patent/NZ578077A/en not_active IP Right Cessation
- 2008-02-12 PT PT87076741T patent/PT2111555E/pt unknown
-
2009
- 2009-07-21 ZA ZA2009/05101A patent/ZA200905101B/en unknown
-
2013
- 2013-07-19 JP JP2013150603A patent/JP5792772B2/ja not_active Expired - Fee Related
- 2013-09-17 US US14/028,971 patent/US20140065170A1/en not_active Abandoned
-
2016
- 2016-10-03 HR HRP20161266TT patent/HRP20161266T1/hr unknown
-
2018
- 2018-01-26 US US15/880,943 patent/US10359406B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010518386A5 (enExample) | ||
| Roubaud Baudron et al. | Extragastric Diseases and H elicobacter pylori | |
| JP2011530514A5 (enExample) | ||
| JP5792772B2 (ja) | 子癇前症の診断及び治療 | |
| JP2012509477A5 (enExample) | ||
| NZ603492A (en) | Humanized anti-factor d antibodies and uses thereof | |
| NZ600828A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| JP2006502416A5 (enExample) | ||
| JP2018519508A5 (enExample) | ||
| SG169395A1 (en) | Detection of cancer by elevated levels of bcl-2 | |
| Hu et al. | Kinetic analysis of β-amyloid peptide aggregation induced by metal ions based on surface plasmon resonance biosensing | |
| JP2012507030A5 (enExample) | ||
| JP2014512014A (ja) | 川崎病の診断マーカーおよび治療標的 | |
| CN107110848B (zh) | 以脱氧羟腐胺缩赖氨酸合酶基因作为指标使用的动脉硬化及癌的检测方法 | |
| JP5801895B2 (ja) | 全身性炎症反応症候群を伴わない術後感染症の検出方法 | |
| CN108738347B (zh) | 辅助肝细胞癌患者的再发风险预测的方法、装置、计算机程序制品及试剂盒 | |
| Haslene-Hox et al. | Quantification of the concentration gradient of biomarkers between ovarian carcinoma interstitial fluid and blood | |
| JP2018520366A5 (enExample) | ||
| AU2020418522A1 (en) | Preeclampsia biomarkers and use thereof | |
| CN112805565A (zh) | 对肝型脂肪酸结合蛋白质进行定量的方法、其定量用试剂盒、肾疾病的检查方法、其检查试剂盒及伴随诊断药 | |
| KR102336498B1 (ko) | 간세포암 진단용 면역글로불린 a 마커 및 이의 용도 | |
| US8697368B2 (en) | Diagnostic marker for lung cancer comprising HPαR as active ingredient | |
| Nishino | Hypocretin measurements in the CSF, and blood and brain tissue: basic and clinical applications | |
| WO2007008092A3 (en) | Diagnostic kit for the examination of animal sera for the presence of anti-rhd antibodies and a diagnostic kit for detecting the rhd virus | |
| KR101251222B1 (ko) | ＡＰＥ1/Ｒｅｆ-1을 함유하는 방광암 진단용 조성물, 및 이를 이용한 방광암 진단 키트 |